ICD-10-CM Code C71.3

Malignant neoplasm of parietal lobe

Version 2020 Billable Code Neoplasm Malignant Primary

Valid for Submission

C71.3 is a billable code used to specify a medical diagnosis of malignant neoplasm of parietal lobe. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code C71.3 might also be used to specify conditions or terms like malignant neoplasm of parietal lobe or neoplasm of parietal lobe or primary malignant neoplasm of parietal lobe.

The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: brain NEC parietal lobe or parietal lobe, brain .

ICD-10:C71.3
Short Description:Malignant neoplasm of parietal lobe
Long Description:Malignant neoplasm of parietal lobe

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Malignant neoplasm of parietal lobe
  • Neoplasm of parietal lobe
  • Primary malignant neoplasm of parietal lobe

Convert C71.3 to ICD-9

  • 191.3 - Mal neo parietal lobe

Code Classification

  • Neoplasms (C00–D48)
    • Malignant neoplasms of eye, brain and other parts of central nervous system (C69-C72)
      • Malignant neoplasm of brain (C71)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020

Table of Neoplasms

The code C71.3 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»brain NEC
  »parietal lobe
C71.3C79.31D33.0D43.0D49.6
»parietal
  »lobe, brain
C71.3C79.31D33.0D43.0D49.6

Information for Patients


Brain Tumors

A brain tumor is a growth of abnormal cells in the tissues of the brain. Brain tumors can be benign, with no cancer cells, or malignant, with cancer cells that grow quickly. Some are primary brain tumors, which start in the brain. Others are metastatic, and they start somewhere else in the body and move to the brain.

Brain tumors can cause many symptoms. Some of the most common are

  • Headaches, often in the morning
  • Nausea and vomiting
  • Changes in your ability to talk, hear, or see
  • Problems with balance or walking
  • Problems with thinking or memory
  • Feeling weak or sleepy
  • Changes in your mood or behavior
  • Seizures

Doctors diagnose brain tumors by doing a neurologic exam and tests including an MRI, CT scan, and biopsy. Treatment options include watchful waiting, surgery, radiation therapy, chemotherapy, and targeted therapy. Targeted therapy uses substances that attack cancer cells without harming normal cells. Many people get a combination of treatments.

NIH: National Cancer Institute


[Learn More]